{
  "company": {
    "name": "Kestrel Therapeutics",
    "website": "https://kestreltherapeutics.com/",
    "record": "https://startuphistory.org/c/kestreltherapeutics.com"
  },
  "status": null,
  "history_since": "2023-03-23T11:59:32.000Z",
  "baseline": {
    "snapshot_id": "552d2721193236ea97096a71114108ec103e959c61f9cb98962ca51e8663f3ce",
    "observed_at": "2023-03-23T11:59:32.000Z",
    "headline": "Targeted Therapy for RAS-driven Cancers",
    "description": "Kestrel Therapeutics discovers and develops new molecules to treat intractable cancers using targeted therapy.",
    "evidence": "https://web.archive.org/web/20230323115932/https://kestreltherapeutics.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 1,
  "last_checked": "2026-11-06T17:28:16.780Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2026-11-06T17:28:16.780Z",
      "variants": [
        {
          "headline": "Targeted Therapy for RAS-driven Cancers",
          "subhead": "Kestrel Therapeutics discovers and develops new molecules to treat intractable cancers using targeted therapy.",
          "observed_at": "2023-03-23T11:59:32.000Z",
          "evidence": "https://web.archive.org/web/20230323115932/https://kestreltherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeted Therapy for RAS-driven Cancers",
          "subhead": "Kestrel Therapeutics discovers and develops new molecules to treat intractable cancers using targeted therapy.",
          "observed_at": "2023-09-24T04:39:13.000Z",
          "evidence": "https://web.archive.org/web/20230924043913/https://kestreltherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeted Therapy for RAS-driven Cancers",
          "subhead": "Kestrel Therapeutics discovers and develops new molecules to treat intractable cancers using targeted therapy.",
          "observed_at": "2024-02-21T12:38:28.000Z",
          "evidence": "https://web.archive.org/web/20240221123828/https://kestreltherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeted Therapy for RAS-driven Cancers",
          "subhead": "Kestrel Therapeutics discovers and develops new molecules to treat intractable cancers using targeted therapy.",
          "observed_at": "2024-07-21T23:43:52.000Z",
          "evidence": "https://web.archive.org/web/20240721234352/https://kestreltherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Targeted Therapy for KRAS-driven Cancers",
          "subhead": "Kestrel Therapeutics discovers and develops new molecules to treat intractable cancers using targeted therapy.",
          "observed_at": "2026-03-09T18:27:12.000Z",
          "evidence": "https://web.archive.org/web/20260309182712/https://kestreltherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing Targeted Therapy for Patients with KRAS-driven Cancers",
          "subhead": "Kestrel Therapeutics discovers and develops new molecules to treat intractable cancers using targeted therapy.",
          "observed_at": "2026-10-03T21:43:07.000Z",
          "evidence": "https://web.archive.org/web/20261003214307/https://kestreltherapeutics.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing Targeted Therapy for Patients with KRAS-driven Cancers",
          "subhead": "Kestrel Therapeutics discovers and develops new molecules to treat intractable cancers using targeted therapy.",
          "observed_at": "2026-11-06T17:28:16.780Z",
          "evidence": "https://kestreltherapeutics.com/",
          "evidence_kind": "live_capture"
        }
      ],
      "headline": "Developing Targeted Therapy for Patients with KRAS-driven Cancers",
      "subhead": "Kestrel Therapeutics discovers and develops new molecules to treat intractable cancers using targeted therapy.",
      "from": "2023-03-23T11:59:32.000Z",
      "to": "2026-11-06T17:28:16.780Z",
      "captures": 7,
      "evidence": "https://kestreltherapeutics.com/",
      "evidence_kind": "live_capture",
      "seen": {
        "between": {
          "from": "2023-03-23T11:59:32.000Z",
          "to": "2026-11-06T17:28:16.780Z"
        }
      },
      "current": true
    }
  ],
  "changes": [],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “Kestrel Therapeutics” company record, https://startuphistory.org/c/kestreltherapeutics.com"
}